Colan Totte Co (TSE:7792) EBIT: 円1,982 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7792 Colan Totte Co Ltd TSE:7792
90 GF Score
Price 円1,460.00
GF Value 円1,539.80
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Colan Totte Co EBIT?

Colan Totte Co TSE:7792 +0.34% 90 EBIT is 円1,982 Mil as of Mar. 2026. GuruFocus rates TSE:7792 with a GF Score™ of 90/100 and a GF Value™ of 円1,539.80 (Fairly Valued). The stock has 2 warning signs investors should review.

Colan Totte Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円503 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,982 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Colan Totte Co's annualized ROC % for the quarter that ended in Mar. 2026 was 29.54%. Colan Totte Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 68.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Colan Totte Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.74%.

Colan Totte Co  (TSE:7792) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Colan Totte Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2013.352 * ( 1 - 32.43% )/( (4817.139 + 4392.125)/ 2 )
=1360.4219464/4604.632
=29.54 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7012.631 - 410.753 - ( 1784.739 - max(0, 1775.171 - 5031.157+1784.739))
=4817.139

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7176.15 - 669.108 - ( 2114.917 - max(0, 1595.878 - 4923.552+2114.917))
=4392.125

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Colan Totte Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2013.352/( ( (1478.613 + max(1471.247, 0)) + (1731.156 + max(1212.757, 0)) )/ 2 )
=2013.352/( ( 2949.86 + 2943.913 )/ 2 )
=2013.352/2946.8865
=68.32 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1274.142 + 1611.368 + 360.908) - (410.753 + 0 + 1364.418)
=1471.247

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(707.689 + 1771.426 + 329.52) - (669.108 + 0 + 926.77)
=1212.757

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Colan Totte Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=1982.167/11174.546
=17.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Colan Totte Co EBIT Related Terms

Colan Totte Co EBIT Historical Data

* Premium members only.

The historical data trend for Colan Totte Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Colan Totte Co EBIT Chart

Colan Totte Co Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT
Get a 7-Day Free Trial 620.54 945.57 1,019.03 1,500.89 1,810.09

Colan Totte Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.02 511.61 353.07 614.15 503.34

TSE:7792 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Colan Totte Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Colan Totte Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Colan Totte Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Colan Totte Co's EV-to-EBIT falls into.


TSE:7792
90GF Score
Colan Totte Co Ltd TSE:7792
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Colan Totte Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,982 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円1,982 Mil mean?
Colan Totte Co (TSE:7792) has a EBIT of 円1,982 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Colan Totte Co.
Is Colan Totte Co's EBIT too high?
Colan Totte Co's current EBIT is 円1,982 Mil. Overall, Colan Totte Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's EBIT compare to ABT and SYK?
Colan Totte Co's EBIT of 円1,982 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Colan Totte Co. Colan Totte Co's current EBIT is 円1,982 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,539.80, compared to a current price of 円1,460.00 — trading 5.2% below its estimated fair value. The current EBIT is 円1,982 Mil. Colan Totte Co's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current EBIT is 円1,982 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Colan Totte Co (TSE:7792) Overvalued in 2026?

Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued. The current stock price of 円1,460.00 is trading 5.2% below its estimated GF Value™ of 円1,539.80. GuruFocus considers Colan Totte Co to be Fairly Valued.

Key valuation signals for TSE:7792:

  • EBIT: 円1,982 Mil
  • GF Value™: 円1,539.80 vs. price of 円1,460.00 (5.2% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Colan Totte Co Business Description

Address 2-10-26 Minamisenba, Colantotte Building, Chuo-ku, Osaka, JPN, 542?0081
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
90GF Score

Get the complete analysis for TSE:7792

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,460.00
Price
円1,539.80
GF Value